Pfizer Gets Final Approval of $50 Million EpiPen Litigation Deal

Pfizer Inc. has been granted final approval of a $50 million deal to settle a yearslong multidistrict dispute with allegations that the company conspired to inflate the price of life-saving EpiPen injections.

Judge Daniel D. Crabtree of the US District Court for the District of Kansas highlighted the settlement’s immediate recovery for a class of direct EpiPen purchasers in a Tuesday order granting final approval.

“This immediate recovery is more valuable than a ‘mere possibility’ that Class Members might achieve a more favorable outcome ‘after protracted and expensive litigation’ that may well last ‘many years in the future,’” Crabtree said. ...